Scilex Holding Company Announces Its Subsidiaries, ACEA Therapeutics, Inc. and ACEA Pharma, Inc., Entered into a Definitive Agreement with Phoenix Asia Holdings Limited
Phoenix Asia Holdings (PHOE) entered into a definitive agreement to acquire ACEA Pharma from Scilex Holding Company (SCLX) for $1 billion in stock. The transaction involves issuing 100 million Phoenix shares at $10.00 per share, with Scilex's subsidiary retaining approximately 82% ownership post-close. Phoenix will be renamed ACEA Pharma, Inc.
Key figures
- Deal Value Usd
- 1000000000
- Offering Price
- 10
- Shares Offered
- 100000000
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.